Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

Clinical trial NCT02378480 · COMPLETED

Trial details

NCT number: NCT02378480
Sponsor: Paratek Pharmaceuticals Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bacterial Infections Skin Structures and Soft Tissue Infections

Start date: 2015-06-01
Primary completion: 2016-04-01
Enrollment: 655

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.